In addition, focusing on the metabolomics aspect could reveal the changes in the levels of different small molecules and glycolytic intermediates, associated with MCT4 expression in cancer tissues, and not limit our observation to only changes in lactate levels. This evidence concerns the gene SLC16A3 and cancer.